US Patent

US10350180 — Solid-forming local anesthetic formulations for pain control

Formulation · Assigned to Crescita Therapeutics Inc · Expires 2031-01-14 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects solid-forming local anesthetic formulations for pain control that can be applied to the skin.

USPTO Abstract

Solid-forming local anesthetic formulations for pain control can include a lidocaine base and tetracaine base, polyvinyl alcohol, water, and an emulsifier. The formulation can be prepared to be in a semi-solid state prior to application to a skin surface, can form a soft solidified layer after application, and can provide pain relief when applied to a skin surface proximate a pain site.

Drugs covered by this patent

Patent Metadata

Patent number: US10350180
Jurisdiction: US
Classification: Formulation
Expires: 2031-01-14
Drug substance claim: No
Drug product claim: Yes
Assignee: Crescita Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.